Generics Bulletin is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alvotech Reels In Abdi Ibrahim For Access To Turkey

Executive Summary

In a move to take its pipeline of biosimilar monoclonal antibodies global, Alvotech has struck a deal with Abdi Ibrahim that will give it localization advantages in Turkey.

Advertisement

Related Content

Alvotech And Fuji Stretch Alliance To Ustekinumab In Japan
Alvotech To Develop Biosimilar Assets With US$300m Financing Deal
Alvotech Advances Partnerships To Take Pipeline Global
Fuji Pharma Invests US$50 Million In Alvotech
Alvotech teams up with China’s Changchun

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

GB140400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel